FIELD: medical virology.
SUBSTANCE: disclosed is a reassortant vaccine strain of influenza A/17/Tasmania/2020/151 (H3N2) virus, deposited in the State Collection of Viruses of the Ivanovskiy Institute of Virology, Federal State Budgetary Institution “Gamaleya Research Institute of Epidemiology and Microbiology” of the Ministry of Health of Russia, under No. 2993. Vaccine strain A/17/Tasmania/2021/151 (H3N2) – reassortant obtained by crossing epidemic virus A/Tasmania/503/2020 (H3N2) with cold-adapted temperature-sensitive virus A/Leningrad/134/17/57 (H2N2) – attenuation donor harmless for people.
EFFECT: strain is characterized by temperature sensitivity, cold adaptation and harmlessness, can be used for production of live intranasal influenza vaccine for prevention of influenza among adults and children.
1 cl, 1 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/MICHIGAN/2020/484 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825583C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/HONG KONG/2019/2573 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783894C1 |
REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/DARWIN/2021/410 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825673C1 |
VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2732610C1 |
VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/3610 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2734897C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/NEWCASTLE/2018/22 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783887C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/SYDNEY/2019/156 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783876C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/SOUTH AUSTRALIA/2019/122 (H3N2) FOR PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783877C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2019/276 (H1N1) PDM09 FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783878C1 |
VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2017/7178 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2711101C1 |
Authors
Dates
2024-08-28—Published
2023-12-21—Filed